Theravance Biopharma Inc (0TB) — Defensive Interval Ratio

Latest as of September 2025: 1690 days

Theravance Biopharma Inc (0TB) has a Defensive Interval Ratio of 1690 days as of September 2025. Defensive assets of €173.17 Million (cash €-, short-term investments €154.91 Million, receivables €18.27 Million) cover 1690 days of daily cash needs of €102.48K/day. Check 0TB tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

1690 days
Days of operational coverage

Defensive Assets

€173.17 Million
Cash + ST Investments + Receivables

Daily Cash Need

€102.48K
Current Liabilities ÷ 365

Current Liabilities

€37.41 Million
EUR

Theravance Biopharma Inc Defensive Interval Ratio (2014–2024)

This chart shows how Theravance Biopharma Inc's Defensive Interval Ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 1690 days, meaning defensive assets of €173.17 Million can fund 1690 days of operations without new revenue. Also explore 0TB net assets growth trend to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Theravance Biopharma Inc (2014–2024)

The table below presents the year-by-year Defensive Interval Ratio for Theravance Biopharma Inc from 2014 to 2024, covering 11 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Theravance Biopharma Inc market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 785 days €68.99 Million €87.90K/day €- €50.55 Million ▼ -399 days
2023 1184 days €80.36 Million €67.85K/day €- €62.88 Million ▲ +598 days
2022 586 days €46.10 Million €78.67K/day €- €29.31 Million ▼ -22 days
2021 608 days €97.57 Million €160.51K/day €- €83.51 Million ▼ -64 days
2020 672 days €227.34 Million €338.55K/day €- €211.47 Million ▼ -222 days
2019 893 days €273.34 Million €306.04K/day €- €222.77 Million ▲ +362 days
2018 531 days €143.35 Million €270.01K/day €- €127.25 Million ▼ -1038 days
2017 1569 days €268.95 Million €171.38K/day €- €259.59 Million ▲ +339 days
2016 1231 days €166.11 Million €134.98K/day €- €156.39 Million ▲ +516 days
2015 715 days €96.88 Million €135.53K/day €- €59.73 Million ▼ -767 days
2014 1482 days €167.53 Million €113.03K/day €- €165.40 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)